Earnings Call for Q3FY21 of Alkem Laboratories
Conference Call with Alkem Laboratories Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript.05-02-2021
05-02-2021
Alkem Laboratories Ltd - 539523 - Closure of Trading Window
We refer to our earlier communication dated 28th December, 2020 regarding closure of trading window (for the purpose of financial results for the quarter ended 31st December, 2020) starting from 30th December, 2020 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and nine months ended 31st December, 2020 are communicated to the Stock Exchanges. The Financial Results of the Company for the quarter and nine months ended 31st December, 2020 having been communicated to the Stock Exchanges, today i.e. 05th February, 2021, the trading window shall open on 08th February, 2021.05-02-2021
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q3FY21 and 9MFY21 earnings and business updates and the same will be uploaded on the website of the Company. Kindly take note of the same.05-02-2021
Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 (LODR)- Cut-Off Date For Postal Ballot
This is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, the Board of Directors at its meeting held today i.e. 05th February, 2021 have decided to seek approval of the shareholders by way of Postal Ballot through remote e-voting for amendments to the Memorandum of Association of the Company. The Company has fixed 13th February, 2021 as cut-off date for ascertaining the eligibility of shareholders for dispatch of Postal Ballot Notice and remote voting through electronic means. Kindly take note of the same.05-02-2021
Alkem Laboratories Ltd - 539523 - Corporate Action-Board approves Dividend
In continuation of our letter dated 27th January, 2021 the Board of Directors of the Company, at its meeting held today, i.e. 05th February, 2021 inter alia, has declared Interim Dividend of Rs.25/- (Rupees Twenty Five only) per equity share on the face value of Rs. 2/- per share for the financial year 2020-21 pursuant to Regulation 43 read with Regulation 30 of the Listing Regulations. The date of payment of Interim Dividend shall be on and from 25th February, 2021.Further, as informed vide our letter dated 27th January, 2020 submitted to the Stock Exchanges pursuant to Regulation 42 of the Listing Regulations, the record date for the purpose of payment of Interim Dividend for the financial year 2020-21 would be Saturday, 13th February, 2021.05-02-2021
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
We wish to inform you that the Board of Directors ('Board') of the Company, at its meeting held today, i.e. 05th February, 2021 have inter alia approved alteration to Memorandum of Association ('MOA') of the Company by adding certain clauses under Part B of Clause III of MOA and carrying out suitable modifications in line with The Companies Act, 2013, subject to the approval of the shareholders of the Company by way of Postal Ballot. Kindly take note of the same.05-02-2021
Alkem Laboratories Ltd - 539523 - Results- Financial Results For Quarter And Nine Months Ended 31St Dec 2020
In continuation of our letter dated 27th January, 2021 and pursuant to Regulation 30 read with Regulation 33 and Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 , the Board of Directors of the Company, at its meeting held today, i.e. 05th February, 2021 have inter alia approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st Dec, 2020. A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Reg 33 of the Listing Regulations, is enclosed herewith. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1.45 pm.05-02-2021
Alkem Laboratories Ltd - 539523 - Results- Financial Results For Quarter And Nine Months Ended 31St Dec 2020
In continuation of our letter dated 27th January, 2021 and pursuant to Regulation 30 read with Regulation 33 and Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 , the Board of Directors of the Company, at its meeting held today, i.e. 05th February, 2021 have inter alia approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st Dec, 2020. A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Reg 33 of the Listing Regulations, is enclosed herewith. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1.45 pm.05-02-2021
Alkem Laboratories Ltd - 539523 - Outcome Of Board Meeting Dated 05/02/2021
Pursuant to Reg 30 read with Reg 33 and Reg 42 of the SEBI (LODR) Regulations, 2015 , the Board of Directors of the Company, at its meeting held today, i.e. 05th February, 2021 have inter alia: a. Approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st Dec, 2020. b. Declared Interim Dividend of Rs. 25/- (Rupees Twenty Five only) per equity share on the face value of Rs. 2/- per share for the financial year 2020-21 pursuant to Regulation 43 read with Regulation 30 of the Listing Regulations. c. Approved the alteration of the Memorandum of Association ('MOA') of the Company, by adding certain clauses under Part B of Clause III of MOA and carrying out suitable modifications in the line with the provisions of the Companies Act, 2013, subject to the approval of the shareholders of the Company through Postal Ballot. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1.45 p.m.05-02-2021
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3FY21 and 9MFY21 financial results will be held on Friday, 05th February, 2021 at 5.30 P.M. Please find attached herewith the conference call details. Kindly take note of the same.29-01-2021